PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026

Core Viewpoint - PAVmed Inc. will host a business update conference call and webcast on March 30, 2026, to discuss its operations and growth strategy, along with the fourth quarter 2025 financial results [1]. Group 1: Conference Call Details - The conference call is scheduled for 8:30 AM ET on March 30, 2026 [1]. - U.S. callers can join by dialing 1-800-836-8184, while international listeners should dial 1-646-357-8785, using the conference call name "PAVmed Business Update" [2]. - A replay of the conference call will be available for 30 days on the investor relations section of the company's website [3]. Group 2: Company Overview - PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors [4]. - The company's subsidiary, Lucid Diagnostics, markets the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device, which are the first commercial tools for early detection of esophageal precancer [4]. - Another subsidiary, Veris Health Inc., focuses on personalized cancer care through remote patient monitoring and is developing an implantable physiological monitor to interface with the Veris Cancer Care Platform [4].